Estimate of prevalent hyperuricemia by systemic inflammation response index: results from a rural Chinese population. Issue 2 (17th February 2021)

• Record Type: Journal Article
• Authors: Chen, Meng-Qi; Wang, Hao-Yu; Shi, Wen-Rui; Sun, Ying-Xian
• Is Part Of: Postgraduate medicine. Volume 133:Issue 2(2021)
• Page Start: 242
• Page End: 249
• Publication Date: 2021-02-17
• Subjects: Hyperuricemia -- systemic inflammation response index -- Inflammation -- Chinese population; Medicine -- Periodicals; Medicine -- Periodicals; Medicine; Periodicals; 610.5
• DOI: 10.1080/00325481.2020.1809870
• Languages: English
• ISSNs: 0032-5481

Abstract

ABSTRACT: Objectives: Hyperuricemia is a common metabolic disease that is intimately correlated with inflammation. Our study aimed to investigate the value of systemic inflammation response index as a novel inflammatory marker to estimate hyperuricemia in the rural Chinese population. Methods: This cross-sectional study used the data of 8, 095 Chinese men and women aged ≥35 years from the 2012–2013 Northeast China Rural Cardiovascular Health Study. Results: The overall prevalence of hyperuricemia was 12.84%. After fully adjusting for potential confounders, each SD increase of SIRI in men and women caused a 21.4% and 37.0% additional risk, respectively, for hyperuricemia. Moreover, smooth curve fitting and subgroup analyses corroborated the linearity and robustness of this correlation. ROC analysis showed the ability of SIRI to estimate hyperuricemia was significantly improved in females (0.741 vs 0.745, P = 0.043), but not in males (0.710 vs 0.714, P = 0.105). The net reclassification improvement (NRI, 0.120 in men vs 0.166 in women) and integrated discrimination improvement (IDI, 0.002 in men vs 0.006 in women) showed a significant improvement for both genders. Conclusions: Our present study suggests a linear and robust relationship between SIRI and prevalent hyperuricemia, which implicates the value of SIRI to optimize the risk stratification and prevention of hyperuricemia.